 |
|
The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma
Jong Hyun Choi, Juwhan Choi, Sang Mi Chung, Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Jae Jeong Shim, Kyung Ho Kang, Hyun Kyung Lee, Sung Yong Lee
Tuberc Respir Dis. 2019;82(3):211-216. Published online 2018 Dec 20 DOI: https://doi.org/10.4046/trd.2018.0019
|
|
Citations to this article as recorded by
 Current Status and Progress in the Treatment of Malignant Pleural Effusion in Lung Cancer
雨家 谷
Advances in Clinical Medicine.2023; 13(08): 13464. CrossRef Development and Internal Validation of a Nomogram Used to Predict Chemotherapy-Induced Neutropenia in Non-Small Cell Lung Cancer Patients: A Retrospective Cohort Study
Wei Zou, Neng-Luan Xu
Cancer Management and Research.2021; Volume 13: 2797. CrossRef
|